A short peptide bioregulator (Khavinson) aimed at the vascular system, blood vessels. Part of the model that aging happens along three tracks (cellular, immune, vascular); Vesugen targets the vascular track in brief courses.
Research referenceCommunity compiled
i
Research & reference information
This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.
Overview
A short peptide bioregulator (Khavinson) aimed at the vascular system, blood vessels.
Part of the model that aging happens along three tracks (cellular, immune, vascular); Vesugen targets the vascular track in brief courses.
What It Does
Vesugen is a Khavinson tripeptide (Lys-Glu-Asp, KED) targeting vascular tissue.
It is proposed to support healthy endothelial/vascular gene expression and function.
Evidence is largely from Russian bioregulator research; used as short pulsed courses.
Reconstitution
Vial Size
BAC Water / Solvent
Concentration
10 mg
+ 5 mL
2 mg/mL
Interactive tool
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Calculated concentration—Enter both values above.
Optional conversion
Enter a target amount you already have and select the syringe capacity.
Calculated draw—Enter concentration inputs and a target amount.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
Phase
Frequency
Amount
Notes
Course (10–20 days)
Daily
1–2 mg SubQ
SubQ. (Oral bioregulator capsules dose higher.)
Between courses
–
–
1–3 courses per year.
Cycle & Timing
10–20 day course, 1–3×/year.
Timing
any time. Note: vascular-targeted bioregulator; evidence is largely Russian research, limited Western RCTs.
Population Considerations
Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy.
Handling & Stacking
Injection site
SubQ, abdomen. Rotate.
Storage
Freeze-dried: -4°F. Reconstituted: 36–46°F, best used within ~4–6 weeks (structure-based estimate), which covers the usual course.
Side effects
Generally well tolerated, mild injection-site reaction. Human safety data limited.
What to expect
Proposed vascular support over a course; subtle, preliminary evidence. Supply math 10mg → 4 vials (20-day course @ 2 mg/day SubQ)
Pairs well with
Other Khavinson bioregulators (cellular/immune/vascular triad); Epithalon; Thymalin
Avoid
Active malignancy (theoretical gene-expression effects). Pregnancy
Safety & Patient Education
Contraindications
Active malignancy (theoretical, tissue gene-expression modulation) Pregnancy and lactation Hypersensitivity to the peptide
Warnings
Limited Western clinical data, most evidence is Russian research Quality varies, request a COA Subtle, course-based effects
Drug interactions
No well-characterized interactions Commonly stacked with other bioregulators in a course
Labs
None compound-specific; vascular/blood-pressure tracking if that’s the goal
Stop criteria
Persistent injection-site reaction Any unexpected cardiovascular or systemic symptom Pregnancy
Patient education
A short-course, vascular-targeted bioregulator; not continuous Evidence is preliminary and largely Russian Subtle effects; manage expectations Request a COA; source quality matters
Standard Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
